Neuromuscular Junction Disorders Flashcards

1
Q

Botulism (Etiology)

A
  • Neurotoxin produced by clostridium botulinum
  • Affects the PREsynaptic cell terminal
  • Anaerobic, Gram positive rods
  • Found in improperly preserved/canned foods & contaminated wounds.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Botulism (Classification/Mode of Acquisition)

A
  • Food borne
  • Wound
  • Unclassified
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
Botulinum Mechanism
(General Overview)
A
  1. Toxin enters PREsynaptic Terminals
  2. Block the fusion of the ACh vesicles with the presynaptic membrane. (myoneural junction)
  3. It inhibits ACh release into the NMJ
  4. Nerve fails to send an impulse across the NMJ
  5. Muscle Paralysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Botulinum Mech (specifics)

A

SNARE protein that helps the vesicle fuse to the membrane is cleaved by the light-chain of the toxin. Without the SNARE protein the vesicle cannot fuse to the membrane.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Incidence of Botulinum

A
  • 10 adult and 100 infant cases each year in the US

- 8-20% overall mortality rate (fatal if not seen within 24 hours, secondary to respiratory failure)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Botulinum- S & S

A

S & S

  • Develop within 12-36 hours following ingestion of food
  • Flaccid Symmetrical paralysis
  • Blurred & Double vision, photophobia, ptosis
  • Dry mouth, nausea, vomiting
  • Difficulty swallowing/speech
  • Can involve muscles of respiration. (respiratory failure in 6-8 hours)
  • NO sensory or autonomic involvement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Prevention of Botulinum

A
  • Boil food x10 mins will destroy the toxin
  • Avoid honey for children under 1yr
  • Take care of wounds and use sterilized equipment.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Interventions to Treat Botulinum

A

-ABE serum antitoxin
- Debridement & Antibiotics for wound
- Removal of toxin from GI tract (pumping the stomach)
Supportive Measures:
- IV
-Mechanical Vent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Botulinum: Recovery

A

Recovery

  • Gradual recovery over weeks and months
  • Typically get fill recovery in both infant and adult.
  • recovery is more about sprouting new terminal nerve filaments and formation of new synapses.
  • NOT repair of the old, MAKING of the new.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

BoTox- Treatment for Individuals with….

A
  • Spinal Cord Injury
  • MS
  • Dystonia
  • Cerebral Vascular Accident
  • Traumatic Brain Injury
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How does Botox work?

A
  • It’s injected intramuscularly (goes through muscle barrier) into specifically selected muscles to generate highly focal weakness.
  • It’s prevents the release of Ach from the PRE-synaptic nerve terminal. Thus blocking Ach transmission at the NMJ.
  • It’s Dose-dependent, and causes a reversible reduction in muscle power.
  • Effects are temporary and muscle weakness resolves over three to four months.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Botulinum: Administration, Determining injection sites

A
  • Larger superficial muscles (ID’d via surface anatomy knowledge).
  • EMG, Nerve or muscle stimulation, ultrasound may be needed for smaller less accessible muscles, or when the muscle is deformed because of fat.
  • Best sites for injection are the nerve end-plate zones deep in muscle bulk.
  • Small and moderate sized muscles will usually respond to BT injected into their belly.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Duration of Effects of BT

A
  • Taken into the NMJ within 12 hours
  • Clinical effect occurs gradually over 4-7 days
  • BT interferes with NMJ synaptic for about 12-16 weeks
  • which causes muscle weakness for 3-4 months.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Post-Injection Management

A
  • PT is mandatory as soon as BT takes effect.
  • Assess the need for orthotics/splints or review existing ones to assess pt compliance
  • Provide pt education on stretching
  • Do not over stretch weakened muscles, stretches should be graded over time to prevent intramuscular hematomas.
  • Increase muscle strength of the opposing muscle groups
  • Consider other treatments that could enhance the effects of the BT (constraint therapy/ electrical stimulation of antagonist)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Botox Side-Effects KNOW

A
  • Problems swallowing, speaking, or breathing due to weakness in associated muscles. (Can be severe and result in loss of life)
  • Most issues stem from inappropriate dose, and bt affecting areas away from injection site.
  • double vision,
  • blurred vision
  • drooping eyelids,
  • hoarseness or change or loss of voice (dysphonia),
  • trouble saying words clearly (dysarthria),
  • loss of bladder control,
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Myasthenia Gravis

A

-POSTsynaptic membrane disease. (at NMJ)

17
Q

MG- Mechanism

A
  • Widened synaptic cleft
  • Loss of folds in the muscles endplate membrane
  • Reduction in number and density of ACh receptors
  • the Ach is less likely to find a receptor before it is hydrolyzed by ACHesterase
  • Results in weakness or paresis
18
Q

Normal vs MG post-synaptic cell characteristic

A

Normal
- Postsynaptic cells have deep wells to catch the Ach and have many receptors on the membrane.
MG
- Loose the deep wells and have less receptors so the cleft gets wider instead of being deep.

19
Q

MG- Etiology

A

-Acquired autoimmune disease
-Past or present viral infection
-70% - hyperplasia (overgrowth) of the thymus
-10- 15% - tumors of the thymus
-Not always sure
Bimodal distribution:
-Younger females (peak incidence age 30 YO)
-Older men (peak incidence age 60 YO)

20
Q

MG- Disease Progression

A
  • Slow, progressive weakness
  • maximal weakness occurs in first year in 2/3 of all cases
  • After 15-20 years, weakness becomes fixed
  • Remissions occur in about 25% of cases